ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer
Clinical trial NCT04662580 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04662580
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-03
- Primary completion
- 2026-12-31
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.